Primary Site >> Liver Cancer

Gene >> TREH

  • 1997
  • 2001
  • 2007
  • 2008
  • 2011
  • 2015
  • 2018
Ref: Dominant negative activity of mutant thyroid hormone alpha1 receptors from patients with hepatocellular carcinoma.
PMID: 9389515
Ref: A hepatocellular carcinoma-specific adenovirus variant, CV890, eliminates distant human liver tumors in combination with doxorubicin.
PMID: 11522637
Ref: [Treatment of mouse liver metastasis by intraportal injection of Adv-p53].
PMID: 18396637
Ref: [Establishment of a tight tetracycline-controlled HCV-C double transgenic mouse model].
PMID: 18819860
Ref: [Killing effects of controllable expression of tumor necrosis factor-related apoptosis-inducing ligand from mesenchymal stem cells on hepatocellular carcinoma cells].
PMID: 21418858
Ref: DLK1-DIO3 genomic imprinted microRNA cluster at 14q32.2 defines a stemlike subtype of hepatocellular carcinoma associated with poor survival.
PMID: 21737452
Ref: Gene signatures derived from a c-MET-driven liver cancer mouse model predict survival of patients with hepatocellular carcinoma.
PMID: 21949730
Ref: Thyroid hormone-mediated regulation of lipocalin 2 through the Met/FAK pathway in liver cancer.
PMID: 25940797
Ref: Notch3 as a novel therapeutic target in metastatic medullary thyroid cancer.
PMID: 29128180